Status:
COMPLETED
Evaluation of the QuantiFERON-TB Test.
Lead Sponsor:
QIAGEN Gaithersburg, Inc
Conditions:
Tuberculosis
Eligibility:
All Genders
18-70 years
Brief Summary
To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.
Detailed Description
To compare the sensitivity of the CST001 assay to the QuantiFERON-TB Gold assay in patients with bacteriologically confirmed and untreated TB disease.
Eligibility Criteria
Inclusion
- Clinical symptoms consistent with a high probability of having TB disease
- Receiving, or are likely to receive, therapy for active TB
- Confirmed tuberculosis by either AFB smear and culture testing, or Nucleic Acid Amplification methods and culture testing.
- Between 18 and 70 years of age.
Exclusion
- Taken therapy for active TB or latent TB for more than 14 days
- Culture confirmation of M. tuberculosis not obtained
Key Trial Info
Start Date :
February 2 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 26 2016
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02253537
Start Date
February 2 2015
End Date
April 26 2016
Last Update
June 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195